It is worth mentioning that we did not find any significant difference in the frequency/intensity of T cells expressing either CXCR3 or CXCR4 among CD26neg/CD26low/CD26high CD8+ T cells in CLL patients (Additional file 1: Fig. S4o–r). This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.